Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

Cited by (689)

Items 101–200 of 689

1. Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivors
   Xinyu Liu, Bo Lu, Hao Thi Tang, Xinmiao Jia, Qingyang Zhou, Yanlin Zeng, Xiaoxing Gao, Minjiang Chen, Yan Xu, Mengzhao Wang et al. · 2024 · EBioMedicine
2. Gut Microbiota and Colorectal Cancer: A Balance Between Risk and Protection
   Vlad Alexandru Ionescu, Camelia Cristina Diaconu, Gina Gheorghe, Mara-Madalina Mihai, Carmen Cristina Diaconu, Marinela Bostan, Coralia Bleoţu · 2025 · International Journal of Molecular Sciences
3. Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy
   Qing Tong, Kexin Li, Fanwei Huang, Yun Dai, Tao Zhang, Munawaer Muaibati, Abuduyilimu Abasi, Xiaoyuan Huang · 2023 · Materials Today Bio
4. Gut microbial structural variation associates with immune checkpoint inhibitor response
   Liu, Rong, Zou, You, Wang, Wei-Quan, Chen, Jun-Hong, Zhang, Lei, Feng, Jia, Yin, Ji-Ye, Mao, Xiao-Yuan, Li, Qing, Luo, Zhi-Ying et al. · 2023 · Nature Communications
5. Akkermansia muciniphila - friend or foe in colorectal cancer?
   Ekaterina O. Gubernatorova, Ekaterina A. Gorshkova, Marina A. Bondareva, Olga A. Podosokorskaya, Anna D. Sheynova, Anastasia S. Yakovleva, Elizaveta A. Bonch-Osmolovskaya, Sergei A. Nedospasov, Andrey Kruglov, Marina S. Drutskaya · 2023 · Frontiers in Immunology
6. Akkermansia muciniphila-derived pentadecanoic acid enhances oxaliplatin sensitivity in gastric cancer by modulating glycolysis
   Qixuan Xu, Jingwang Gao, Ruiyang Zhao, Hanghang Li, Hao Cui, Zhen Yuan, Huiguang Ren, Bo Cao, Bo Wei · 2024 · Pharmacological Research
7. Gut Microbiome-Based Management of Patients With Heart Failure
   Petra Mamic, Michael P. Snyder, W.H. Wilson Tang · 2023 · Journal of the American College of Cardiology
8. Akkermansia muciniphila: a potential booster to improve the effectiveness of cancer immunotherapy
   Shiying Fan, Zhengting Jiang, Zhilin Zhang, Juan Xing, Daorong Wang, Dong Tang · 2023 · Journal of Cancer Research and Clinical Oncology
9. Microbiota in cancer: molecular mechanisms and therapeutic interventions
   Zhou Chen, Defeng Guan, Zhengfeng Wang, Xin Li, Shi Dong, Junjun Huang, Wence Zhou · 2023 · MedComm
10. The gut microbiota improves the efficacy of immune-checkpoint inhibitor immunotherapy against tumors: From association to cause and effect
    Liliang Xia, Xiaokuan Zhu, Ying Wang, Shun Lü · 2024 · Cancer Letters
11. Gut dysbiosis conveys psychological stress to activate LRP5/β-catenin pathway promoting cancer stemness
    Cui Bai, Huandong Luo, Bin He, Xinyu Liu, Dekang Lv, Xiaoyu Zhang, Keyu Su, Sijia Zheng, Jinxin Lü, Cenxin Wang et al. · 2025 · Signal Transduction and Targeted Therapy
12. Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors
    Lin, Anqi, Huang, Lihaoyun, Jiang, Aimin, Zhu, Lingxuan, Mou, Weiming, Li, Yu, Zhang, Chunyan, Liu, Zaoqu, Zhang, Jian, Cheng, Quan et al. · 2025 · BMC Medicine
13. Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis
    Taiki Hakozaki, Alexis Nolin-Lapalme, Masato Kogawa, Yusuke Okuma, Shohei Nakamura, Danielle Moreau-Amaru, Taichi Tamura, Yukio Hosomi, Haruko Takeyama, Corentin Richard et al. · 2022 · Cancers
14. Data-driven prediction of colonization outcomes for complex microbial communities
    Wu, Lu, Wang, Xu-Wen, Tao, Zining, Wang, Tong, Zuo, Wenlong, Zeng, Yu, Liu, Yang-Yu, Dai, Lei · 2024 · Nature Communications
15. Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes
    Jiexi Yan, Lu Yang, Qingmiao Ren, Chan Zhu, Huimin Du, Zhouyu Wang, Yajuan Qi, Xiaohong Xian, Dongsheng Chen · 2024 · Frontiers in Immunology
16. Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non–Small-Cell Lung Cancer
    Arielle Elkrief, Meagan Montesion, Smruthy Sivakumar, Caryn R. Hale, Anita S. Bowman, Ayyüce Begüm Bektaş, Martina Bradić, Wenfei Kang, Eric Chan, Pooja Gogia et al. · 2024 · Journal of Clinical Oncology
17. Taurine prevents mitochondrial dysfunction and protects mitochondria from reactive oxygen species and deuterium toxicity
    Stephanie Seneff, Anthony M. Kyriakopoulos · 2025 · Amino Acids
18. Health and Disease:Akkermansia muciniphila, the Shining Star of the Gut Flora
    Chen Xue, Ganglei Li, Xinyu Gu, Yuanshuai Su, Qiuxian Zheng, Xin Hiu Yuan, Zhengyi Bao, Juan Lu, Lanjuan Li · 2023 · Research
19. Mild SARS-CoV-2 infection results in long-lasting microbiota instability
    Vaibhav Upadhyay, Rahul K. Suryawanshi, Preston Tasoff, Maria McCavitt-Malvido, Renuka Kumar, Victoria Murray, Cecilia A. Noecker, Jordan E. Bisanz, Yulin Hswen, Connie W. Y. Ha et al. · 2023 · mBio
20. A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy
    Xiaoqiang Zhu, Xiaowen Huang, Muni Hu, Rongrong Sun, Jiantao Li, Hai Wang, Xuefeng Pan, Yanru Ma, Lijun Ning, Tianying Tong et al. · 2024 · Cell Host & Microbe
21. Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy
    Davar, Diwakar, Zarour, Hassane M. · 2022 · Clinical Cancer Research
22. Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations
    Yusuke Tomita, Shinya Sakata, Kosuke Imamura, Shinji Iyama, Takayuki Jodai, Koichi Saruwatari, Shohei Hamada, Kimitaka Akaike, Moriyasu Anai, K Fukusima et al. · 2023 · Cancers
23. Engineered bacteria in tumor immunotherapy
    Hua Chen, Yinrui Zhu, Chonghai Zhang, Lin Tao Hu, Kai Yang · 2024 · Cancer Letters
24. Gut microbiome model predicts response to neoadjuvant immunotherapy plus chemoradiotherapy in rectal cancer
    Zhengyang Yang, Jingxin Ma, Jiagang Han, Ang Li, Gang Liu, Yi Sun, Jianyong Zheng, Jie Zhang, Guangyong Chen, Rui‐Hua Xu et al. · 2024 · Med
25. Alistipes finegoldii augments the efficacy of immunotherapy against solid tumors
    Zhi‐Ying Wu, Qiwen Wu, Yi Han, Shu-Jing Xiang, Yingnan Wang, Wen-Wei Wu, Yan‐Xing Chen, Ziqing Feng, Yi-Yu Wang, Ze-Gong Xu et al. · 2025 · Cancer Cell
26. Collinsella aerofaciens Produces a pH-Responsive Lipid Immunogen
    Jaeyoung Kwon, Munhyung Bae, Dávid Szamosvári, Chelsi D. Cassilly, Andrew S. Bolze, David R. Jackson, Ramnik J. Xavier, Jon Clardy · 2023 · Journal of the American Chemical Society
27. Unveiling the intratumoral microbiota within cancer landscapes
    Shusheng Che, Zhiyong Yan, Yugong Feng, Zhao Hai · 2024 · iScience
28. From microbiome to metabolism: Bridging a two-decade translational gap
    Matthias Van Hul, Patrice D. Cani · 2025 · Cell Metabolism
29. Science-Driven Nutritional Interventions for the Prevention and Treatment of Cancer
    Montégut, Léa, de Cabo, Rafael, Zitvogel, Laurence, Kroemer, Guido · 2022 · Cancer Discovery
30. The intratumoral microbiota: friend or foe?
    Valentina Ferrari, María Rescigno · 2023 · Trends in cancer
31. Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability
    Katiane Tostes, Aléxia Polo Siqueira, Rui Manuel Reis, Letícia Ferro Leal, Lídia Maria Rebolho Batista Arantes · 2023 · International Journal of Molecular Sciences
32. Insights into the Mechanisms of Action of Akkermansia muciniphila in the Treatment of Non-Communicable Diseases
    Honorata Mruk-Mazurkiewicz, Monika Kulaszyńska, Wiktoria Czarnecka, Albert Podkówka, Natalia Ekstedt, Piotr Zawodny, Anna Wierzbicka-Woś, Wojciech M. Marlicz, Błażej Skupin, Ewa Stachowska et al. · 2024 · Nutrients
33. Gut Microbiota Modulation through Akkermansia spp . Supplementation Increases CAR T-cell Potency
    Laura Marcos-Kovandzic, Michele Avagliano, Myriam Ben Khelil, Janesa Srikanthan, Rim Abdallah, Valentina Petrocelli, Jessica Rengassamy, Alexia Alfaro, Mathilde Bied, Marine Fidelle et al. · 2025 · Cancer Discovery
34. The gut microbiota modulates responses to anti–PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors
    Zhaozhen Wu, Sujie Zhang, Lingling Li, Ziwei Huang, Di Huang, Yi Hu · 2022 · Frontiers in Oncology
35. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects
    Maximilian Boesch, Lena Horvath, Florent Baty, Andreas Pircher, Dominik Georg Friedrich Wolf, Stephan Spahn, Ravid Straussman, Herbert Tilg, Martin Hugo Brutsche · 2022 · Journal for ImmunoTherapy of Cancer
36. Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer
    Lucile Pabst, Sébastien Lopes, Basil Bertrand, Quentin Creusot, Maria Kotovskaya, Erwan Pencreach, Michèle Beau‐Faller, Céline Mascaux · 2023 · International Journal of Molecular Sciences
37. Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy
    Siyuan Cheng, Zihan Han, Die Dai, Fang Li, Xiaotian Zhang, Ming Shian Lu, Zhihao Lü, Xicheng Wang, Jun Zhou, Jian Li et al. · 2024 · Cell Reports Medicine
38. Harnessing gut microbiota for colorectal cancer therapy: from clinical insights to therapeutic innovations
    Chaofan Chen, Qi Su, Min Zi, Xiaokun Hua, Zhiyun Zhang · 2025 · npj Biofilms and Microbiomes
39. Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle
    Sami Antoun, Émilie Lanoy, Samy Ammari, Siham Farhane, Lisa Martin, Caroline Robert, David Planchard, Émilie Routier, Anne-Laure Voisin, Sabine Messayke et al. · 2022 · European Journal of Cancer
40. Microbiota-mediated mechanisms of mucosal immunity across the lifespan
    Iliyan Dimitrov Iliev, Julie Magarian Blander, Nicholas Collins, Chun‐Jun Guo, Randy Longman, Gregory F. Sonnenberg, Melody Yue Zeng, David Artis · 2025 · Nature Immunology
41. Gut microbiome as a biomarker for predicting early recurrence of HBV ‐related hepatocellular carcinoma
    Chongming Zheng, Fei Lü, Bo Chen, Jinhuan Yang, Haitao Yu, Daojie Wang, Haonan Xie, Kaiwen Chen, Yitong Xie, Jiacheng Li et al. · 2023 · Cancer Science
42. Resistance to immune checkpoint inhibitors in gastric cancer
    Kai Liu, Shiman Yuan, Chenyu Wang, Hong Zhu · 2023 · Frontiers in Pharmacology
43. Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality
    Guillot, Nicolas, Roméo, Barnabé, Manesh, Shima Sepehri, Milano, Gerard, Brest, Patrick, Zitvogel, Laurence, Hofman, Paul, Mograbi, Baharia · 2023 · Trends in Molecular Medicine
44. Potential Ability of Probiotics in the Prevention and Treatment of Colorectal Cancer
    Jiahao Zhao, Yiqun Liao, Chen Wei, Yichao Ma, Fei Wang, Yuji Chen, Bin Zhao, Hao Ji, Daorong Wang, Dong Tang · 2023 · Clinical Medicine Insights Oncology
45. Predicting patient outcomes after treatment with immune checkpoint blockade: A review of biomarkers derived from diverse data modalities
    Yang Liu, Jennifer Altreuter, Sudheshna Bodapati, Simona Cristea, Cheryl J. Wong, Catherine J. Wu, Franziska Michor · 2023 · Cell Genomics
46. Respiratory diseases and the gut microbiota: an updated review
    Yu Xin, Xiao Yu, Yubo Wang, Xiaoping Guo, Chao Wang, Fang Wang · 2025 · Frontiers in Cellular and Infection Microbiology
47. Microbiome influencers of checkpoint blockade–associated toxicity
    Yinghong Wang, Robert R. Jenq, Jennifer Ann Wargo, Stephanie S. Watowich · 2023 · The Journal of Experimental Medicine
48. Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial
    Alves Costa Silva, Carolina, Piccinno, Gianmarco, Suissa, Déborah, Bourgin, Mélanie, Schreibelt, Gerty, Durand, Sylvère, Birebent, Roxanne, Fidelle, Marine, Sow, Cissé, Aprahamian, Fanny et al. · 2024 · Nature Communications
49. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application
    Yu-Pei Zhuang, Hongli Zhou, Haibin Chen, Ming-Yue Zheng, Yuwei Liang, Yu-Tian Gu, Wenting Li, Wenli Qiu, Hongguang Zhou · 2023 · Biomedicine & Pharmacotherapy
50. Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic
    Alejandro Ríos-Hoyo, Edurne Arriola · 2023 · Frontiers in Immunology
51. Predictors of response to immunotherapy in colorectal cancer
    Jaime González‐Montero, Carlos I Rojas, Mauricio Burotto · 2024 · The Oncologist
52. From bench to bedside: an interdisciplinary journey through the gut-lung axis with insights into lung cancer and immunotherapy
    Dávid Dóra, Emőke Szőcs, Ádám Soós, Viktória Halasy, Csenge Somodi, Anna Mihucz, Melinda Rostás, Fruzsina Mógor, Zoltán Lohinai, Nándor Nagy · 2024 · Frontiers in Immunology
53. Gut microbiota therapy in gastrointestinal diseases
    Hanif Ullah, Safia Arbab, Chengting Chang, Saira Bibi, Nehaz Muhammad, Sajid Ur Rehman, Suleman Suleman, Irfan Ullah, Inam Ul Hassan, Yali Tian et al. · 2025 · Frontiers in Cell and Developmental Biology
54. MS-20 enhances the gut microbiota-associated antitumor effects of anti-PD1 antibody
    Lee, Pei-Jung, Hung, Chien-Min, Yang, Ai-Jen, Hou, Cheng-Yu, Chou, Hung-Wen, Chang, Yi-Chung, Chu, Wen-Cheng, Huang, Wen-Yen, Kuo, Wen-Chih, Yang, Chia-Chun et al. · 2024 · Gut Microbes
55. Effects of the intestinal microbiota on prostate cancer treatment by androgen deprivation therapy
    Safae Aarab Terrisse, Laurence Zitvogel, Guido Kroemer · 2022 · Microbial Cell
56. Host–pathobiont interactions in Crohn’s disease
    Roberta Caruso, Bernard C. Lo, Grace Chen, Gabriel Núñez · 2024 · Nature Reviews Gastroenterology & Hepatology
57. Blautia coccoides and its metabolic products enhance the efficacy of bladder cancer immunotherapy by promoting CD8+ T cell infiltration
    Benlin Wang, Wen-Tai Shangguan, Wei-Jia Li, M. Xie, Yao Yu, Qi-Sheng Yang, Qi Sun, Jingwen Xue, Zhang-Rui Zhu, Yuexuan Zhu et al. · 2024 · Journal of Translational Medicine
58. The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunity
    Hao Wu, Jiena Liu, Xinghua Zhang, Shengye Jin, Ping Li, Hui-di Liu, Li Zhao, Jianyu Wang, Shilu Zhao, Hong-Da Tian et al. · 2025 · Drug Resistance Updates
59. Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship
    Arielle Elkrief, Bertrand Routy, Lisa Derosa, Laura A. Bolte, Jennifer Ann Wargo, Jennifer Leigh McQuade, Laurence Zitvogel · 2025 · American Society of Clinical Oncology Educational Book
60. A Review of the Role of Oral Microbiome in the Development, Detection, and Management of Head and Neck Squamous Cell Cancers
    Kimberly M. Burcher, Jack T. Burcher, Logan Inscore, Chance H. Bloomer, Cristina M. Furdui, Mercedes Porosnicu · 2022 · Cancers
61. <i>Helicobacter pylori</i> serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors
    Tonneau, Marion, Nolin-Lapalme, Alexis, Kazandjian, Suzanne, Auclin, Edouard, Panasci, Justin, Benlaifaoui, Myriam, Ponce, Mayra, Al-Saleh, Afnan, Belkaid, Wiam, Naimi, Sabrine et al. · 2022 · OncoImmunology
62. Achilles’ Heel of currently approved immune checkpoint inhibitors: immune related adverse events
    Ting Yan, Lun Yu, Jiwen Zhang, Yun Chen, Yilan Fu, Jingyi Tang, Dehua Liao · 2024 · Frontiers in Immunology
63. The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions
    Hanan Qasem, Wael Mohamed El-Sayed · 2024 · Clinical and Experimental Medicine
64. Navigating the duality of Akkermansia muciniphila
    Erica T. Grant, Elena Monzel, Mahesh S. Desai · 2026 · Nature Microbiology
65. Microbiota-induced T cell plasticity enables immune-mediated tumour control
    Tariq Ahmad Najar, Yuan Hao, Yuhan Hao, Gabriela Romero‐Meza, Alexandra Dolynuk, Emma Almo, Dan R. Littman · 2026 · Nature
66. Future indications and clinical management for fecal microbiota transplantation (FMT) in immuno-oncology
    Jamal, Rahima, Messaoudene, Meriem, de Figuieredo, Marina, Routy, Bertrand · 2023 · Seminars in Immunology
67. Microbiota as the unifying factor behind the hallmarks of cancer
    Iva Benešová, Ľudmila Křížová, Miloslav Kverka · 2023 · Journal of Cancer Research and Clinical Oncology
68. Clade-specific extracellular vesicles from Akkermansia muciniphila mediate competitive colonization via direct inhibition and immune stimulation
    Moon-Gi Hong, Eun‐Ji Song, Hye Jin Yoon, Won‐Hyong Chung, Hae Yeong Seo, Dohak Kim, Dokyung Lee, Jae‐Gu Seo, Hayoung Lee, Seungil Kim et al. · 2025 · Nature Communications
69. The multifaceted roles of Akkermansia muciniphila in neurological disorders
    Xin Ma, Qiang Liu, Guan Yang · 2025 · Trends in Neurosciences
70. Xuanfei Baidu decoction ameliorates bleomycin-elicited idiopathic pulmonary fibrosis in mice by regulating the lung-gut crosstalk via IFNγ/STAT1/STAT3 axis
    Mengjie Jia, Yiman Liu, Jia Liu, Junyu Meng, Jiazhen Cao, Lin Miao, Han Zhang, Yan Zhu, Mengmeng Sun, Jian Yang · 2024 · Phytomedicine
71. Gut microbiota in colorectal cancer: a review of its influence on tumor immune surveillance and therapeutic response
    Chunlei Zhang, Yong Wang, Lei Cheng, Xiansheng Cao, Chunyuan Liu · 2025 · Frontiers in Oncology
72. Akkermansia muciniphila-derived SCFAs improve the depression-like behaviors of mice by inhibiting neuroinflammation
    Jiaolin Wang, Jing Xie, Fei He, Wentao Wu, Ke Cheng XU, Yi Ren, Jianjun Chen, Peng Xie · 2025 · Pharmacological Research
73. Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients
    Anna Grenda, Ewelina Iwan, Paweł Adam Krawczyk, Małgorzata Frąk, Izabela Chmielewska, Arkadiusz Bomba, Aleksandra Giza, Anna Rolska-Kopińska, Michał Szczyrek, Robert Kieszko et al. · 2022 · Cancers
74. Gut microbiota and dietary intervention: affecting immunotherapy efficacy in non–small cell lung cancer
    Yu Xin, Chenguang Liu, Dan Zang, Jun Chen · 2024 · Frontiers in Immunology
75. Gut–lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy
    Huaiyuan Zhang, Ziyuan Xu · 2023 · Frontiers in Oncology
76. The biotherapeutic Clostridium butyricum MIYAIRI 588 strain potentiates enterotropism of Rorγt + Treg and PD-1 blockade efficacy
    Thomas Paz del Socorro, Kentaro Oka, Olivier Boulard, Motomichi Takahashi, Lionel Franz Poulin, Atsushi Hayashi, Mathias Chamaillard · 2024 · Gut Microbes
77. CD69 and SBK1 as potential predictors of responses to PD-1/PD-L1 blockade cancer immunotherapy in lung cancer and melanoma
    Zhangwei Hu, Wei Sun, Yihui Wen, Renqiang Ma, Lin Chen, Wenqing Chen, Wenbin Lei, Wei-Ping Wen · 2022 · Frontiers in Immunology
78. Microbiome meets immunotherapy: unlocking the hidden predictors of immune checkpoint inhibitors
    Huang, Lihaoyun, Li, Yu, Zhang, Chunyan, Jiang, Aimin, Zhu, Lingxuan, Mou, Weiming, Li, Kailai, Zhang, Jian, Cui, Cui, Cui, Xinfang et al. · 2025 · npj Biofilms and Microbiomes
79. Harnessing phytochemicals: Innovative strategies to enhance cancer immunotherapy
    Qianru Zhu, Ruonan Zhang, Ziming Zhao, Tian Xie, Xinbing Sui · 2025 · Drug Resistance Updates
80. Short-chain fatty acids: key antiviral mediators of gut microbiota
    Zhiqiang Xu, Tao Wang, Yanjin Wang, Yongfeng Li, Yuan Sun, Hua‐Ji Qiu · 2025 · Frontiers in Immunology
81. The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer
    Philip Bredin, Jarushka Naidoo · 2022 · Cancer and Metastasis Reviews
82. Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit
    Yael Haberman, Iris Kamer, Amnon Amir, Sapir Goldenberg, Gilat Efroni, Inbal Daniel‐Meshulam, Anastasiya Lobachov, Sameh Daher, Rotem Hadar, Hadas Gantz-Sorotsky et al. · 2023 · Scientific Reports
83. Metformin as a booster of cancer immunotherapy
    Jutatip Panaampon, Yubin Zhou, Charupong Saengboonmee · 2023 · International Immunopharmacology
84. Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
    Liqin Yao, Qingqing Wang, Wenxue Ma · 2023 · Cancers
85. Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers
    Xinyu Wu, Yi Fung Chau, Hua Bai, Xiaofei Zhuang, Jie Wang, Jianchun Duan · 2023 · Frontiers in Oncology
86. The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer
    Sreya Duttagupta, Taiki Hakozaki, Bertrand Routy, Meriem Messaoudene · 2023 · Current Oncology
87. Akkermansia muciniphila outer membrane protein regulates recruitment of CD8 + T cells in lung adenocarcinoma and through JAK – STAT signalling pathway
    Yufen Xu, Xiaoli Tan, Qi Yang, Zhixian Fang, Wenyu Chen · 2024 · Microbial Biotechnology
88. Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment
    Anne T. Knisely, Yongwoo David Seo, Jennifer Ann Wargo, Manoj Chelvanambi · 2023 · Cancers
89. Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer
    Ting Wang, Linguangjin Wu, Shuyun Wang, Xiaolan Shi, Hui Liu, Wanli Deng · 2023 · Chinese Journal of Natural Medicines
90. Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study
    Francesco Schettini, Alessandra Fontana, Federica Gattazzo, Carla Strina, Manuela Milani, Maria Rosa Cappelletti, Valeria Cervoni, Lorenzo Morelli, Giuseppe Curigliano, Valerio Iebba et al. · 2023 · European Journal of Cancer
91. Characterization and Preliminary Safety Evaluation of Akkermansia muciniphila PROBIO
    Xin Ma, Meng Tian, Xueping Yu, Ming Liu, Bin Li, Dayong Ren, Wei Wang · 2024 · Foods
92. Molecular mechanisms of cancer cachexia. Role of exercise training
    Eva Tamayo-Torres, Amanda Garrido, Rafael de Cabo, Julián Carretero, Mari Carmen Gómez‐Cabrera · 2024 · Molecular Aspects of Medicine
93. The Role of Diet and Gut Microbiota Interactions in Metabolic Homeostasis
    Lizhi Guan, Ruixin Liu · 2023 · Advanced Biology
94. Gut dysbiosis in oncology: a risk factor for immunoresistance
    2026
95. Gut microbiota-derived autoinducer-2 regulates lung inflammation through the gut-lung axis
    Xianghao Zeng, Huawen Yue, Ling Zhang, Guimei Chen, Zheng Qiao, Qing Hu, Xinhao Du, Qian Tian, Xinyu Zhao, Lanfan Liang et al. · 2023 · International Immunopharmacology
96. Resistance to immunotherapy in non-small cell lung cancer: Unraveling causes, developing effective strategies, and exploring potential breakthroughs
    Shuang Dong, Xiaoyu Li, Qing Huang, Yuanxiang Li, Jinjiao Li, Xianmin Zhu, Chang Xue, Runzhi Chen, Yuan Zeng, Jingyi Wu et al. · 2025 · Drug Resistance Updates
97. Function and therapeutic potential of Amuc_1100, an outer membrane protein of Akkermansia muciniphila: A review
    Xuhui Wu, Dahai Yu, Yunkun Ma, Xuexun Fang, Pengda Sun · 2025 · International Journal of Biological Macromolecules
98. Microbiome Modulation for the Treatment of Solid Neoplasms
    Regina Barragán-Carrillo, Zeynep Büşra Zengin, Sumanta Kumar Pal · 2025 · Journal of Clinical Oncology
99. Meta-analysis of 22,710 human microbiome metagenomes defines an oral-to-gut microbial enrichment score and associations with host health and disease
    Paolo Manghi, Giacomo Antonello, Lucas Schiffer, Davide Golzato, Andres Wokaty, Francesco Beghini, Chloe A. Mirzayi, Kaelyn Long, Kai Gravel-Pucillo, Gianmarco Piccinno et al. · 2025 · Nature Communications
100. Biomarkers of response to immunotherapy in early stage non-small cell lung cancer
     Matthieu Roulleaux Dugage, Víctor Albarrán-Artahona, Juan Carlos Laguna, Nathalie Chaput, Stéphane Vignot, Benjamin Besse, Laura Mezquita, Édouard Auclin · 2023 · European Journal of Cancer